Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.5700+0.1600 (+4.69%)
At close: 04:00PM EDT
3.5500 -0.02 (-0.56%)
After hours: 07:06PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
140,702
144,927
33,215
34,505
28,267
Operating expenses
Research development
152,237
141,891
90,570
80,141
95,955
Selling general and administrative
76,091
69,261
30,775
24,748
32,596
Total operating expenses
225,620
209,420
121,345
104,889
128,551
Operating income or loss
-84,918
-64,493
-88,130
-70,384
-100,284
Interest expense
3,126
2,910
2,924
502
-
Total other income/expenses net
-981
-1,045
981
-426
170
Income before tax
-86,737
-65,578
-89,127
-70,279
-98,942
Income from continuing operations
-86,737
-65,578
-89,127
-70,279
-98,942
Net income
-86,737
-65,578
-89,127
-70,279
-98,942
Net income available to common shareholders
-86,737
-65,578
-89,127
-70,279
-98,942
Basic EPS
-
-
-1.12
-1.24
-2.43
Diluted EPS
-
-
-1.12
-1.24
-2.43
Basic average shares
-
-
79,789
56,649
40,743
Diluted average shares
-
-
79,789
56,649
40,743
EBITDA
-
-56,721
-79,625
-62,174
-92,422